Cephalexin

Product NDC
66116-607
11-digit product format
661160607
Labeler code
66116
Product ID
66116-607_ca2ed054-b1a5-4174-b107-a26d8c9b31b2
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Cephalexin
Dosage form
POWDER, FOR SUSPENSION
Route
ORAL
Labeler
MedVantx, Inc.
Application
ANDA062703
Marketing category
ANDA
Marketing start
1990-09-30
Marketing end
0000-00-00
Substance
CEPHALEXIN
Active strength
250 mg/5mL
Pharmacologic classes
Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dfa3f520-409c-432e-b6d3-9250d468c772Product name120250401
64bb7f1a-2c2e-4741-8301-dbfeda7239f6Product name120190628
398aa563-bb78-fe0f-46a8-757c40ef28bfProduct name120140508

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
66116-607-20Cephalexin200 mL in 1 BOTTLEPOWDER, FOR SUSPENSION2001

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
CEPHALEXINACTIVE INGREDIENTOBN7UDS42YCEPHALEXIN POWDER, FOR SUSPENSION [MEDVANTX, INC.]1
CEPHALEXIN ANHYDROUSACTIVE MOIETY5SFF1W6677CEPHALEXIN POWDER, FOR SUSPENSION [MEDVANTX, INC.]1
BENZYL ALCOHOLINACTIVE INGREDIENTLKG8494WBHCEPHALEXIN POWDER, FOR SUSPENSION [MEDVANTX, INC.]1
FD&C RED NO. 40INACTIVE INGREDIENTWZB9127XOACEPHALEXIN POWDER, FOR SUSPENSION [MEDVANTX, INC.]1
MALTODEXTRININACTIVE INGREDIENT7CVR7L4A2DCEPHALEXIN POWDER, FOR SUSPENSION [MEDVANTX, INC.]1
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4CEPHALEXIN POWDER, FOR SUSPENSION [MEDVANTX, INC.]1
SODIUM BENZOATEINACTIVE INGREDIENTOJ245FE5EUCEPHALEXIN POWDER, FOR SUSPENSION [MEDVANTX, INC.]1
SUCROSEINACTIVE INGREDIENTC151H8M554CEPHALEXIN POWDER, FOR SUSPENSION [MEDVANTX, INC.]1
XANTHAN GUMINACTIVE INGREDIENTTTV12P4NEECEPHALEXIN POWDER, FOR SUSPENSION [MEDVANTX, INC.]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
66116-607CEPHALEXIN POWDER, FOR SUSPENSION [MEDVANTX, INC.]1Legacy NDC, 1 package rows20140201_ca2ed054-b1a5-4174-b107-a26d8c9b31b2.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
309113cephalexin 250 MG in 5 mL Oral SuspensionPSNca2ed054-b1a5-4174-b107-a26d8c9b31b21
309113cephalexin 50 MG/ML Oral SuspensionSCDca2ed054-b1a5-4174-b107-a26d8c9b31b21
309113cefalexin 50 MG/ML Oral SuspensionSYca2ed054-b1a5-4174-b107-a26d8c9b31b21
309113cephalexin 250 MG per 5 ML Oral SuspensionSYca2ed054-b1a5-4174-b107-a26d8c9b31b21

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsStatus
66116-607-2066116060720200 mL in 1 BOTTLE200 mlHistorical